Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip

Bone

Volumn 33, Issue 3, 2003, Pages 346-351

  Berger, Christian E ^a   Kröner, Andreas H ^a   Minai Pour, Michael B ^a   Ogris, Emil ^a   Engel, Alfred ^a  

^a DANUBE HOSPITAL   (Austria)

Author keywords

Biochemical markers; Bone metabolism; Hip; Transient bone marrow edema syndrome

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; C TERMINAL CROSS LINKING TELOPEPTIDE; OSTEOCALCIN; PEPTIDE; PROCOLLAGEN TYPE 1 N TERMINAL PROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPIRATION; BLOOD ANALYSIS; BONE BIOPSY; BONE MARROW DISEASE; BONE MARROW EDEMA SYNDROME; BONE METABOLISM; BONE NECROSIS; BONE TURNOVER; CANCELLOUS BONE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DECOMPRESSION SURGERY; FEMALE; FEMUR HEAD; HIP; HIP DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METABOLITE; MICROTOME; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; OSTEOID; PROTEIN BLOOD LEVEL; RADIOGRAPHY;

EID: 0042834340     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00164-9     Document Type: Article

References (31)

1. Berger C.E., Kröner A., Stiegler H., Erdel M., Haas O., Engel A. Hypofibrinolysis, lipoprotein(a), and plasminogen activator inhibitor. Clin Orthop. 397:2002;342-349.
2. Hofmann S., Engel A., Neuhold A., Leder K., Kramer J., Plenk H. Jr. Bone marrow oedema syndrome and transient osteoporosis of the hip. An MRI-controlled study of treatment by core decompression. J Bone Joint Surg. 75-Br:1993;210-216.
3. Koo K.H., Jeong S.T., Jones J.P. Borderline necrosis of the femoral fead. Clin Orthop. 358:1999;158-165.
4. Hofmann S., Kramer J., Schneider W., Plenk H. Jr. Transient osteoporosis may represent a reversible early form of avascular necrosis of the hip joint. Curr Orthop. 11:1997;164-172.
5. Mont M.A., Hungerford D.S. Current concepts review nontraumatic avascular necrosis of the femoral head . J Bone Joint Surg. 77A:1995;459-474.
6. Guerra J.J., Steinberg M.E. Distinguishing transient osteporosis from avascular necrosis of the hip. J Bone J Surg. 77A:1995;616-624.
7. Yamamoto T., Kubo T., Hirasawa Y., Noguchi Y., Iwamoto Y., Sueishi K. A clinicopathologic study of transient osteoporosis of the hip. Skel Radiol. 28:1999;621-627.
8. Plotkin L.L., Weinstein R.S., Parfitt A.M., Roberson P.K., Manolagas S.C., Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 104:1999;1363-1374.
9. Chernetsky S.G., Mont M.A., LaPorte D.M., Jones L.C., Hungerford D.S., McCarthy E.F. Pathologic features in steroid and nonsteroid associated osteonecrosis. Clin Orthop. 368:1999;149-161.
10. Plenk H. Jr, Hofmann S., Eschberger J., Gstettner M., Kramer J., Schneider W., Engel A. Histomorphology and morphometry of the bone marrow edema syndrome of the hip. Clin Orthop. 334:1997;78-84.
11. Delmas P.D. Biochemical markers for the assessment of bone turnover. Riggs L.B., Melton J. Osteoporosis etiology and management . 1995;319-332 Lippincott-Raven, Philadelphia, PA.
12. Hakala M., Aman S., Luukkainen R., Risteli L., Kauppi M., Nieminen P., Risteli J. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis. 54:1995;886-890.
13. Miedany E.L., Mehanna A.N., Baddini M.A. Altered bone metabolism in patients with osteoarthritis. Joint Bone Spine. 67:2000;521-527.
14. Prockop D.J., Kivirkko K.I., Tuderman L., Guzman N.A. The biosynthesis of collagen and its disorders. N Engl J Med. 301:1979;13-23.
15. Sharif M., George E., Dieppe P.A. Correlation between synovial fluid markers of cartilage and bone turnover and scintigraphic scan abnormalities in osteoarthritis of the knee. Arthritis Rheum. 38:1995;78-81.
16. Berger C.E., Kröner A., Thomas E., Kristen K.H., Ogris E., Engel A. Comparison of biochemical markers of bone metabolism in serum and distal femur aspirates. Clin Orthop. 395:2002;174-179.
17. Solomon L. Bone marrow edema syndrome. J Bone Joint Surg. 75Br:1993;175-176.
18. Irisa T., Yamamoto T., Miyanishi K., Yamashita A., Iwamoto Y., Sugiola Y., Sueishi K. Osteonecrosis induced by a single administration of low-dose lipopolysaccharide in rabbits. Bone. 28:2001;641-649.
19. Aigner N., Petje G., Schneider W., Krasny C., Grill F., Landsiedl F. Juvenile bone marrow edema of the acetabulum treated by iloprost. J Bone Joint Surg. 84Br:2002;1050-1052.
20. Weinstein R.S., Jilka R.L., Parfitt A.M., Manolagas S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of the deleterious effects on bone. J Clin Invest. 102:1998;274-282.
21. Sato M., Sugano N., Ohzono K., Nomura S., Kitamura Y., Tsukamoto Y., Ogawa S. Apoptosis and expression of stress protein (ORP150, HO1) during development of ischemic osteonecrosis in the rat. J Bone Joint Surg. 83Br:2001;751-759.
22. McCarthy E.F. The pathology of regional transient osteoporosis. Iowa Orthop. 18:1998;35-42.
23. Arlet J., Ficat P., Durroux R. Histopathologie des lesions osseous dans 9 cas d'algodystrophie de la hanche. Rev Rhumat. 45:1978;691-698.
24. Bullough P.G. Osteonecrosis. Ann Pathol. 21:2001;512-523.
25. Miyanishi K., Yamamoto T., Nakashima Y., Shuto T., Jingushi S., Noguchi Y., Iwamoto Y. Subchondral changes in transient osteoporosis of the hip. Skeletal Radiol. 30:2001;255-261.
26. Eriksen E., Charles P., Melsen F., Mosekilde L., Risteli L., Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease correlation with bone histomorphometry . J Bone Miner Res. 8:1993;127-132.
27. Risteli J. Biochemical markers of bone metabolism. Ann Med. 25:1993;385-393.
28. Lakhanpal S., Ginsburg W.W., Luthra H.S., Hunder G.G. Transient regional osteoporosis. Ann Intern Med. 106:1987;444-450.
29. Miller MD. Basic sciences. In: Review of orthopedics, 3rd Ed. Philadelphia, PA: Saunders; 2000.
30. Varenna M., Zucchi F., Binelli L., Failoni S., Gallazzi M., Sinigaglia L. Intravenous pamidronate in the treatment of transient osteoporosis of the hip. Bone. 31:2002;96-101.
31. Soucacos P.N., Beris A.E., Malizos K., Koropilias A., Zalavras H., Dailian Z. Treatment of avascular necrosis of the femoral head with vascularized fibular transplant. Clin Orthop. 386:2001;120-130.